• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

迟发性阿尔茨海默病患者无患病一级亲属的认知功能:系统文献回顾和荟萃分析。

Cognitive Functioning of Unaffected First-degree Relatives of Individuals With Late-onset Alzheimer's Disease: A Systematic Literature Review and Meta-analysis.

机构信息

Department of Psychology and Brain Health Research Centre, University of Otago, Dunedin, New Zealand.

Brain Research New Zealand, Auckland, New Zealand.

出版信息

Neuropsychol Rev. 2023 Dec;33(4):659-674. doi: 10.1007/s11065-022-09555-2. Epub 2022 Sep 3.

DOI:10.1007/s11065-022-09555-2
PMID:36057684
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10770217/
Abstract

First-degree relatives of individuals with late-onset Alzheimer's disease (LOAD) are at increased risk for developing dementia, yet the associations between family history of LOAD and cognitive dysfunction remain unclear. In this quantitative review, we provide the first meta-analysis on the cognitive profile of unaffected first-degree blood relatives of LOAD-affected individuals compared to controls without a family history of LOAD. A systematic literature search was conducted in PsycINFO, PubMed /MEDLINE, and Scopus. We fitted a three-level structural equation modeling meta-analysis to control for non-independent effect sizes. Heterogeneity and risk of publication bias were also investigated. Thirty-four studies enabled us to estimate 218 effect sizes across several cognitive domains. Overall, first-degree relatives (n = 4,086, mean age = 57.40, SD = 4.71) showed significantly inferior cognitive performance (Hedges' g = -0.16; 95% CI, -0.25 to -0.08; p < .001) compared to controls (n = 2,388, mean age = 58.43, SD = 5.69). Specifically, controls outperformed first-degree relatives in language, visuospatial and verbal long-term memory, executive functions, verbal short-term memory, and verbal IQ. Among the first-degree relatives, APOE ɛ4 carriership was associated with more significant dysfunction in cognition (g = -0.24; 95% CI, -0.38 to -0.11; p < .001) compared to non-carriers (g = -0.14; 95% CI, -0.28 to -0.01; p = .04). Cognitive test type was significantly associated with between-group differences, accounting for 65% (R = .6499) of the effect size heterogeneity in the fitted regression model. No evidence of publication bias was found. The current findings provide support for mild but robust cognitive dysfunction in first-degree relatives of LOAD-affected individuals that appears to be moderated by cognitive domain, cognitive test type, and APOE ɛ4.

摘要

一级亲属

一级亲属

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abc1/10770217/7f4291c0dad8/11065_2022_9555_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abc1/10770217/c0661767423c/11065_2022_9555_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abc1/10770217/b985b0b6eaf3/11065_2022_9555_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abc1/10770217/7f4291c0dad8/11065_2022_9555_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abc1/10770217/c0661767423c/11065_2022_9555_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abc1/10770217/b985b0b6eaf3/11065_2022_9555_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abc1/10770217/7f4291c0dad8/11065_2022_9555_Fig3_HTML.jpg

相似文献

1
Cognitive Functioning of Unaffected First-degree Relatives of Individuals With Late-onset Alzheimer's Disease: A Systematic Literature Review and Meta-analysis.迟发性阿尔茨海默病患者无患病一级亲属的认知功能:系统文献回顾和荟萃分析。
Neuropsychol Rev. 2023 Dec;33(4):659-674. doi: 10.1007/s11065-022-09555-2. Epub 2022 Sep 3.
2
Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).血浆和脑脊液β淀粉样蛋白用于诊断轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2014 Jun 10;2014(6):CD008782. doi: 10.1002/14651858.CD008782.pub4.
3
Selegiline for Alzheimer's disease.司来吉兰用于治疗阿尔茨海默病。
Cochrane Database Syst Rev. 2003(1):CD000442. doi: 10.1002/14651858.CD000442.
4
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.
5
Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis.胆碱酯酶抑制剂治疗血管性痴呆和其他血管性认知障碍:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Feb 22;2(2):CD013306. doi: 10.1002/14651858.CD013306.pub2.
6
Psychological therapies for panic disorder with or without agoraphobia in adults: a network meta-analysis.成人伴或不伴有广场恐惧症的惊恐障碍的心理治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2016 Apr 13;4(4):CD011004. doi: 10.1002/14651858.CD011004.pub2.
7
Vitamin E for Alzheimer's dementia and mild cognitive impairment.维生素E用于治疗阿尔茨海默病性痴呆和轻度认知障碍。
Cochrane Database Syst Rev. 2017 Apr 18;4(4):CD002854. doi: 10.1002/14651858.CD002854.pub5.
8
Cholinesterase inhibitors for rarer dementias associated with neurological conditions.用于治疗与神经疾病相关的罕见痴呆症的胆碱酯酶抑制剂。
Cochrane Database Syst Rev. 2015 Mar 3;2015(3):CD009444. doi: 10.1002/14651858.CD009444.pub3.
9
Pharmacotherapies for sleep disturbances in Alzheimer's disease.用于治疗阿尔茨海默病睡眠障碍的药物疗法。
Cochrane Database Syst Rev. 2014 Mar 21(3):CD009178. doi: 10.1002/14651858.CD009178.pub2.
10
Vitamin E for Alzheimer's dementia and mild cognitive impairment.维生素E用于治疗阿尔茨海默病性痴呆和轻度认知障碍。
Cochrane Database Syst Rev. 2017 Jan 27;1(1):CD002854. doi: 10.1002/14651858.CD002854.pub4.

引用本文的文献

1
Single-value brain activity scores reflect both severity and risk across the Alzheimer's continuum.单值脑活动评分反映了阿尔茨海默病连续体中的严重程度和风险。
Brain. 2024 Nov 4;147(11):3789-3803. doi: 10.1093/brain/awae149.
2
Falls and Sleep Disorders in Spanish Alzheimer's Disease in Nursing Homes: An Observational Study.养老院中西班牙裔阿尔茨海默病患者的跌倒与睡眠障碍:一项观察性研究。
Healthcare (Basel). 2023 Oct 30;11(21):2852. doi: 10.3390/healthcare11212852.
3
Exploratory Longitudinal Study of Ocular Structural and Visual Functional Changes in Subjects at High Genetic Risk of Developing Alzheimer's Disease.

本文引用的文献

1
Aging, Senescence, and Dementia.衰老、衰老和痴呆。
J Prev Alzheimers Dis. 2022;9(3):523-531. doi: 10.14283/jpad.2022.42.
2
ApoE Cascade Hypothesis in the pathogenesis of Alzheimer's disease and related dementias.载脂蛋白 E 级联假说在阿尔茨海默病及相关痴呆发病机制中的作用。
Neuron. 2022 Apr 20;110(8):1304-1317. doi: 10.1016/j.neuron.2022.03.004. Epub 2022 Mar 16.
3
Four distinct trajectories of tau deposition identified in Alzheimer's disease.阿尔茨海默病中tau 沉积的四种不同轨迹。
阿尔茨海默病高遗传风险受试者眼部结构和视觉功能变化的探索性纵向研究。
Biomedicines. 2023 Jul 18;11(7):2024. doi: 10.3390/biomedicines11072024.
4
Genetic association between the APOE ε4 allele, toxicant exposures and Gulf war illness diagnosis.载脂蛋白 E ε4 等位基因、毒物暴露与海湾战争病诊断之间的遗传关联。
Environ Health. 2023 Jul 6;22(1):51. doi: 10.1186/s12940-023-01002-w.
Nat Med. 2021 May;27(5):871-881. doi: 10.1038/s41591-021-01309-6. Epub 2021 Apr 29.
4
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
5
: The New Frontier in the Development of a Therapeutic Target towards Precision Medicine in Late-Onset Alzheimer's.: 开发治疗靶点以实现晚期阿尔茨海默病精准医学的新前沿。
Int J Mol Sci. 2021 Jan 27;22(3):1244. doi: 10.3390/ijms22031244.
6
A cross-sectional examination of a family history of Alzheimer's disease and ApoE epsilon 4 on physical fitness, molecular biomarkers, and neurocognitive performance.横断面研究阿尔茨海默病家族史和 ApoE ε4 对身体适应性、分子生物标志物和神经认知表现的影响。
Physiol Behav. 2021 Mar 1;230:113268. doi: 10.1016/j.physbeh.2020.113268. Epub 2020 Dec 28.
7
Linguistic markers predict onset of Alzheimer's disease.语言标记可预测阿尔茨海默病的发病。
EClinicalMedicine. 2020 Oct 22;28:100583. doi: 10.1016/j.eclinm.2020.100583. eCollection 2020 Nov.
8
The Israel Registry for Alzheimer's Prevention (IRAP) Study: Design and Baseline Characteristics.以色列预防老年痴呆症登记研究(IRAP):设计与基线特征。
J Alzheimers Dis. 2020;78(2):777-788. doi: 10.3233/JAD-200623.
9
Biological subtypes of Alzheimer disease: A systematic review and meta-analysis.阿尔茨海默病的生物学亚型:系统评价和荟萃分析。
Neurology. 2020 Mar 10;94(10):436-448. doi: 10.1212/WNL.0000000000009058. Epub 2020 Feb 11.
10
Disrupted functional connectivity of the locus coeruleus in healthy adults with parental history of Alzheimer's disease.有阿尔茨海默病家族史的健康成年人中蓝斑核的功能连接中断。
J Psychiatr Res. 2020 Apr;123:81-88. doi: 10.1016/j.jpsychires.2020.01.018. Epub 2020 Jan 30.